Nuvation Bio Inc. (NUVB)

Nuvation Bio Statistics

Total Valuation

Nuvation Bio has a market cap or net worth of $731.57 million. The enterprise value is $281.30 million.

Market Cap	731.57M
Enterprise Value	281.30M

Important Dates

The last earnings date was Wednesday, May 7, 2025, after market close.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Nuvation Bio has 340.26 million shares outstanding. The number of shares has increased by 36.40% in one year.

Current Share Class	339.26M
Shares Outstanding	340.26M
Shares Change (YoY)	+36.40%
Shares Change (QoQ)	+0.50%
Owned by Insiders (%)	24.88%
Owned by Institutions (%)	50.57%
Float	229.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	58.61
Forward PS	104.43
PB Ratio	1.74
P/TBV Ratio	1.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	25.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.01, with a Debt / Equity ratio of 0.03.

Current Ratio	9.01
Quick Ratio	8.85
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-522.44

Financial Efficiency

Return on equity (ROE) is -119.66% and return on invested capital (ROIC) is -25.08%.

Return on Equity (ROE)	-119.66%
Return on Assets (ROA)	-23.33%
Return on Invested Capital (ROIC)	-25.08%
Return on Capital Employed (ROCE)	-46.93%
Revenue Per Employee	$49,805
Profits Per Employee	-$2.76M
Employee Count	220
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.85% in the last 52 weeks. The beta is 1.42, so Nuvation Bio's price volatility has been higher than the market average.

Beta (5Y)	1.42
52-Week Price Change	-33.85%
50-Day Moving Average	1.99
200-Day Moving Average	2.50
Relative Strength Index (RSI)	53.21
Average Volume (20 Days)	3,147,446

Short Selling Information

The latest short interest is 30.81 million, so 9.05% of the outstanding shares have been sold short.

Short Interest	30.81M
Short Previous Month	28.39M
Short % of Shares Out	9.05%
Short % of Float	13.42%
Short Ratio (days to cover)	10.26

Income Statement

In the last 12 months, Nuvation Bio had revenue of $10.96 million and -$606.38 million in losses. Loss per share was -$2.03.

Revenue	10.96M
Gross Profit	1.79M
Operating Income	-206.36M
Pretax Income	-510.72M
Net Income	-606.38M
EBITDA	-205.43M
EBIT	-206.36M
Loss Per Share	-$2.03

Balance Sheet

The company has $461.68 million in cash and $11.41 million in debt, giving a net cash position of $450.26 million or $1.32 per share.

Cash & Cash Equivalents	461.68M
Total Debt	11.41M
Net Cash	450.26M
Net Cash Per Share	$1.32
Equity (Book Value)	419.46M
Book Value Per Share	1.23
Working Capital	422.80M

Cash Flow

In the last 12 months, operating cash flow was -$157.34 million and capital expenditures -$207,000, giving a free cash flow of -$157.55 million.

Operating Cash Flow	-157.34M
Capital Expenditures	-207,000
Free Cash Flow	-157.55M
FCF Per Share	-$0.46

Margins

Gross Margin	16.29%
Operating Margin	-1,883.38%
Pretax Margin	-5,534.21%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Nuvation Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.40%
Shareholder Yield	-36.40%
Earnings Yield	-82.89%
FCF Yield	-21.54%

Analyst Forecast

The average price target for Nuvation Bio is $8.20, which is 281.40% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.20
Price Target Difference	281.40%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	118.73%
EPS Growth Forecast (5Y)	-24.15%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nuvation Bio has an Altman Z-Score of 3.55 and a Piotroski F-Score of 1.

Altman Z-Score	3.55
Piotroski F-Score	1